HbA1c: an important measure of how effectively diabetes can be managed using a measure of the amount of glucose that has attached itself to each red blood cell over the preceding 2-3 months to assess the level of diabetes control.
The DCCT (Diabetes Control and Complications Trial) study confirmed that lowering HbA1c by just 1% can decrease the risk of developing microvascular complications by up to 40%.* HbA1c should be monitored every 3 months with the goal of keeping it below 7% (53 mmol/L) or at the target set by your diabetes healthcare team.
Normal glucose values vary between 4.0 and 7.8 mmol/L, and you may want to consider trying to achieve these targets in daily life with self-monitoring of blood glucose (SMBG) levels using a personal glucose meter.*
"What can I say? Now with the pump it's no longer diabetes controlling me, but it's me having control over diabetes."
Many people find it a challenge to keep HbA1c low in target range without increasing the risk of hypoglycaemia. Insulin pump therapy enables instant adjustments in insulin requirements.
Achieving blood glucose control is therefore important. Some of the best ways to do this while reducing the occurance of hypoglycaemia are:
- Dosing insulin more regularly in smaller amounts*
- Balancing glucose levels before and after exercise
- Adjusting insulin dose to match the carbohydrates in meals
- Adjusting insulin dosing according to daily activities
- Knowing when and how to adjust therapy by monitoring glucose levels throughout the day
It can be a challenge to reach and maintain the HbA1C goal whilst minimising the risk of hypoglycaemia. Insulin pump therapy enables adjustments in insulin requirements to meet the body`s needs.